Zasloff Michael A's Form 4 filing
Amphastar Pharmaceuticals, Inc. (AMPH) · filed Mar 6, 2024
- Accession no.
- 0001415889-24-007093
- Filed
- Mar 6, 2024
- Trade date
- Mar 5, 2024
- Filing delay
- 1 day
- Rule 10b5-1 plan
- Not checked
This filing lists 2 non-derivative transactions and 0 derivative transactions. Open-market sales total $589.7K. It was filed 1 day after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Zasloff Michael ACIK 0001033511 | Director |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Mar 5, 2024 | Common Stock | SSaleDisposed | −9,389 | $47.06 | −$441,846.34 | 24,437 | Direct | |
| Mar 5, 2024 | Common Stock | SSaleDisposed | −3,111 | $47.53 | −$147,865.83 | 21,326 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.